Strive, Inc. is advancing its integration of Semler Scientific through a distinctive two-part corporate strategy. The company is merging traditional medical technology with an assertive program of Bitcoin acquisition. Holding more than 13,600 Bitcoins, the corporation now ranks among the world’s largest corporate owners of the cryptocurrency.
Managing a Digital Treasury Alongside Core Operations
The completion of the Semler Scientific acquisition in mid-January has brought considerable Bitcoin reserves into Strive’s holdings, in addition to medical expertise. As of the reporting date of March 17, 2026, the company’s balance sheet showed approximately 13,628 Bitcoin. Leadership’s stated objective is to consistently grow the Bitcoin holdings per share, thereby supporting the firm’s valuation beyond its core operational business.
Concurrently, vascular diagnostics remains a fundamental pillar. Management is focused on profitably expanding the early detection products from Clinivanta, formerly a Semler Scientific subsidiary. This segment is expected to be stabilized under Avik Roy, the new Chief Strategy Officer, and Clinivanta CEO Michelle Fox. The medical technology division has historically faced revenue volatility, making its future operational performance a key point of observation for market participants.
Should investors sell immediately? Or is it worth buying Semler Scientific?
Liquidity and Integration in Focus
Investors are closely monitoring how Strive manages liquidity to fund additional acquisitions while navigating the balance sheet impact of its crypto portfolio’s inherent volatility. The successful integration of its diverse business units and the strategic management of its digital assets are viewed as primary drivers for the company’s future valuation.
The most recent annual financial results for 2025 were published on March 19, 2026. The next significant milestone on the corporate calendar is the upcoming quarterly earnings release, which is anticipated to occur between July 1 and July 2, 2026.
Ad
Semler Scientific Stock: Buy or Sell?! New Semler Scientific Analysis from March 29 delivers the answer:
The latest Semler Scientific figures speak for themselves: Urgent action needed for Semler Scientific investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 29.
Semler Scientific: Buy or sell? Read more here...
